COVID-19 in a human T-cell lymphotropic virus type-1 carrier.
Takatoshi EnomotoTakayuki ShiroyamaHaruhiko HirataSaori AmiyaYuichi AdachiTakayuki NiitsuYoshimi NodaReina HaraKiyoharu FukushimaYasuhiko SugaKotaro MiyakeShohei KoyamaKota IwahoriIzumi NagatomoNatsuko TokuhiraAkinori UchiyamaYoshito TakedaAtsushi KumanogohPublished in: Clinical case reports (2022)
This is the first report of COVID-19 in a human T-cell lymphotropic virus type-1 (HTLV-1) carrier. HTLV-1 infection can cause immune dysfunction even in asymptomatic carriers. This case highlights the need for guidance on management of COVID-19-HTLV-1 coinfection, specifically on the appropriate use of corticosteroid treatment while considering secondary infection.